Mutational analysis of the propensity for amyloid formation by a globular protein

EMBO Journal

Volumn 19, Issue 7, 2000, Pages 1441-1449

  Chiti, Fabrizio ^a,b   Taddei, Niccolò ^b   Bucciantini, Monica ^b   White, Paul ^a   Ramponi, Giampietro ^b   Dobson, Christopher M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acylphosphatase; Amyloid fibrils; Conformational stability; Protein engineering; Protein misfolding

Indexed keywords

ACYLPHOSPHATASE; AMYLOID; GLOBULAR PROTEIN; MUTANT PROTEIN; TRIFLUOROETHANOL;

AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DENATURATION; PROTEIN INTERACTION; PROTEIN STABILITY; THEORY;

EID: 0034599720     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/19.7.1441     Document Type: Article

References (46)

1. Bauer, H.H., Aebi, U., Haner, M., Hermann, R., Muller, M., Arvinte, T. and Merkle, H.P. (1995) Architecture and polymorphism of fibrillar supramolecular assemblies produced by in vitro aggregation of human calcitonin. J. Struct. Biol., 115, 1-15.
2. Baures, P.W., Oza, V.B., Peterson, S.A. and Kelly, J.W. (1999) Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug flufenamic acid. Bioorg. Med. Chem., 7, 1339-1347.
3. Booth, D.R. et al. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature, 385, 787-793.
4. Bullock, A.N., Henckel, J., DeDecker, B.S., Johnson, C.M., Nikolova, P.V., Proctor, M.R., Lane, D.P. and Fersht, A.R. (1997) Thermodynamic stability of wild-type and mutant p53 core domain. Proc. Natl Acad. Sci. USA, 94, 14338-14342.
5. Chiti, F., Taddei, N., van Nuland, N.A.J., Magherini, F., Stefani, M., Ramponi, G. and Dobson, C.M. (1998a) Structural characterisation of the transition state for folding of muscle acylphosphatase. J. Mol. Biol., 283, 893-903.
6. Chiti, F., van Nuland, N.A.J., Taddei, N., Magherini, F., Stefani, M., Ramponi, G. and Dobson, C.M. (1998b) Conformational stability of muscle acylphosphatase. The role of temperature, denaturant concentration and pH. Biochemistry, 37, 1447-1455.
7. Chiti, F., Webster, P., Taddei, N., Clark, A., Stefani, M., Ramponi, G. and Dobson, C.M. (1999a) Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc. Natl Acad. Sci. USA, 96, 3590-3594.
8. Chiti, F., Taddei, N., White, P.W., Bucciantini, M., Magherini, F., Stefani, M. and Dobson, C.M. (1999b) Mutational analysis of AcP suggests the importance of topology and contact order in protein folding. Nature Struct. Biol., 6, 1005-1010.
9. Chiti, F., Taddei, N., Webster, P., Hamada, D., Fiaschi, T. Ramponi, G. and Dobson, C.M. (1999c) Acceleration of the folding of acylphosphatase by stabilisation of local secondary structure. Nature Struct. Biol., 6, 380-387.
10. Conway, K.A., Harper, J.D. and Lansbury, P.T. (1998) Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nature Med., 11, 1318-1320.
11. Dobson, C.M. (1999) Protein misfolding, evolution and disease. Trends Biochem. Sci., 9, 329-332.
12. Fink, A.L. (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des., 3, R9-R23.
13. Funahashi, J., Takano, K., Ogasahara, K., Yamagata, Y. and Yutani, K. (1996) The structure, stability and folding process of amyloidogenic mutant human lysozyme. J. Biochem., 120, 1216-1223.
14. Glenner, G.G., Ein, D., Eanes, E.D., Bladen, H.A., Terry, W. and Page, D.L. (1971) Creation of 'amyloid' fibrils from Bence Jones proteins in vitro. Science, 174, 712-714.
15. Goldsbury, C.S. et al. (1997) Polymorphic fibrillar assembly of human amylin. J. Struct. Biol., 119, 17-27.
16. Gross, M., Wilkins, D.K., Pitkeathly, M.C., Chung, E.W., Higham, C., Clark, A. and Dobson, C.M. (1999) Formation of amyloid fibrils by peptides derived from the bacterial cold shock protein CspB. Protein Sci., 8, 1350-1357.
17. Guijarro, J.I., Sunde, M., Jones, J.A., Campbell, I.D. and Dobson, C.M. (1998) Amyloid fibril formation by an SH3 domain. Proc. Natl Acad. Sci. USA, 95, 4224-4228.
18. Harper, J.D., Lieber, C.M. and Lansbury, P.T. (1997) Observation of metastable Aβ amyloid protofibrils by atomic force microscopy. Chem. Biol., 4, 951-959.
19. Hurle, M.R., Helms, L.R., Li, L., Chan, W. and Wetzel, R. (1994) A role for destabilising amino acid replacements in light chain amyloidosis. Proc. Natl Acad Sci. USA, 91, 5446-5450.
20. Jimenez, J.L., Guijarro, J.L., Orlova, E., Zurdo, J., Dobson, C.M., Sunde, M. and Saibil, H.R. (1999) Cryo-electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing. EMBO J., 18, 815-821.
21. Kelly, J.W. (1996) Alternative conformations of amyloidogenic proteins govern their behavior. Curr. Opin. Struct. Biol., 6, 11-17.
22. Lai, Z., Colon, W. and Kelly, J.W. (1996) The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid. Biochemistry, 35, 6470-6482.
23. Lansbury, P.T. (1999) Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease. Proc. Natl Acad. Sci. USA, 96, 3342-3344.
24. LeVine III, H. (1995) Thioflavine T interaction with amyloid β-sheet structures. Amyloid: Int. J. Exp. Clin. Invest., 2, 1-6.
25. Liemann, S. and Glockshuber, R. (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry, 38, 3258-3267.
26. Litvinovich, S.V., Brew, S.A., Aota, S., Akiyama, S.K., Haudenschild, C. and Ingham, K.C. (1998) Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. J. Mol. Biol., 280, 245-258.
27. McCutchen, S.L., Lai, Z.H., Miroy, G.J., Kelly, J.W. and Colon, W. (1995) Comparison of lethal and nonlethal transthyrethin variants and their relationship to amyloid disease. Biochemistry, 34, 13527-13536.
28. Merz, P.A., Wisniewski, H.M. Somerville, R.A., Bobin, S.A., Masters, C.L. and Iqbal, K. (1983) Ultrastructural morphology of amyloid fibrils from neuritic and amyloid plaques. Acta Neuropathol., 60, 113-124.
29. Miroy, G.J., Lai, Z.H., Lashuel, H.A., Peterson, S.A., Strang, C. and Kelly, J.W. (1996) Inhibiting transthyretin amyloid fibril formation via protein stabilization. Proc. Natl Acad. Sci. USA, 93, 15051-15056.
30. Modesti, A., Taddei, N., Chiti, F., Bucciantini, M., Magherini, F., Rigacci, S., Stefani, M. Raugei, G. and Ramponi, G. (1996) Properties of Cys21-mutated muscle acylphosphatases. J. Protein Chem., 15, 27-34.
31. Pastore, A., Saudek, V., Ramponi, G. and Williams, R.J.P. (1992) Three-dimensional structure of acylphosphatase. Refinement and structure analysis. J. Mol. Biol., 224, 427-440.
32. Perutz, M.F. (1999) Glutamine repeats and neurodegenerative diseases: molecular aspects. Trends Biochem. Sci., 24, 58-63.
33. Santoro, M.M. and Bolen, D.W. (1988) Unfolding free-energy changes determined by the linear extrapolation method. I. Unfolding of phenylmethanesulfonyl α-chymotrypsin using different denaturants. Biochemistry, 27, 8063-8068.
34. 1H NMR spectrum of an enzyme, horse muscle acylphosphatase. Eur. J. Biochem., 182, 85-93.
35. Selkoe, D.J. (1996) Amyloid β-protein and the genetics of Alzheimer's disease. J. Biol. Chem., 271, 18295-18298.
36. Serpell, L.C., Sunde, M., Fraser, P.E., Luther, P.K., Morris, E.P., Sangren, O., Lundgren, E. and Blake, C.C.F. (1995) Examination of the structure of the transthyretin amyloid fibril by image reconstruction from electron micrographs. J. Mol. Biol., 254, 113-118.
37. Shirahama, T. and Cohen, A.S. (1967) High resolution electron microscopic analysis of the amyloid fibril. J. Cell Biol., 33, 679-706.
38. Shirahama, T., Benson, M.D., Cohen, A.S. and Tanaka, A. (1973) Fibrillar assemblage of variable segments of immunoglobulin light chains: an electron microscopy study. J. Immunol., 110, 21-30.
39. Sletten, K., Westermark, P. and Natvig, J.B. (1976) Characterisation of amyloid fibril proteins from medullary carcinoma of the thyroid. J. Exp. Med., 143, 993-998.
40. Smith, L.J., Fiebig, K.M., Schwalbe, H. and Dobson, C.M. (1996) The concept of a random coil - Residual structure in peptides and denatured proteins. Fold. Des., 1, R95-R106.
41. Sunde, M. and Blake, C. (1997) The structure of amyloid fibrils by electron microscopy and X-ray diffraction. Adv. Protein Chem., 50, 123-159.
42. Swietnicki, W., Petersen, R.B., Gambetti, P. and Surewicz, W.K. (1998) Familial mutations and the thermodynamic stability of the recombinant human prion protein. J. Biol. Chem., 273, 31048-31052.
43. Taddei, N., Stefani, M., Magherini, F., Chitli, F., Modesti, A., Raugei, G. and Ramponi, G. (1996) Looking for residues involved in muscle acylphosphatase catalytic mechanism and structural stabilization: the role of Asn41, Thr42 and Thr46. Biochemistry, 35, 7077-7083.
44. Tan, S.Y. and Pepys, M.B. (1994) Amyloidosis. Histopathology, 25, 403-414.
45. van Nuland, N.A.J., Chiti, F., Taddei, N., Raugei, G., Ramponi, G. and Dobson, C.M. (1998) Slow folding of muscle acylphosphatase in the absence of intermediates. J. Mol. Biol. 283, 883-891.
46. Wetzel, R. (1997) Inhibition of amyloid assembly. J. Neurochem., 69, S104.